IN8BIOINAB

13F holders, Q1 2026 (March 31)
19holders −3
1new positions
4sold out
$1.48avg. 13F price*

At the end of Q1 2026, 19 institutions reported holding IN8BIO Inc. (INAB) in their 13F filings, down 3 from Q4 2025. 1 opened new positions and 4 sold out. The largest holders were Alyeska Investment Group, L.P. ($1.4M), Franklin Resources Inc. ($1.4M) and 683 Capital Management, LLC ($1.1M).

Company
IN8BIO Inc.
CUSIP
45674E208
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q2 2025: 11Q2 2025Q3 2025: 18Q3 2025Q4 2025: 22Q4 2025Q1 2026: 19Q1 2026Q2 2026: 21Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions1$36K
Exits4$100K

All 13F filers, Q4 2025 → Q1 2026: 605,862 shares bought and 148,527 shares sold, net +457,335 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 19 holders

Alyeska Investment Group, L.P. 0.00% Reduce -1.4% 944,319 $1.4M
Franklin Resources Inc. 0.00% No change 914,531 $1.4M
683 Capital Management, LLC 0.10% No change 724,637 $1.1M
Stonepine Capital Management, LLC 0.86% Add +302.3% 663,412 $982K
BIOS Capital Management, LP 0.47% Reduce -33.8% 167,805 $248K
Vanguard Capital Management LLC 0.00% — 88,865 $132K
Geode Capital Management, LLC 0.00% Add +311.3% 86,239 $128K
Vanguard Fiduciary Trust Co. 0.00% — 43,570 $65K
Captrust Financial Advisors 0.00% Add +82.0% 33,295 $49K
Oppenheimer & Co. Inc. 0.00% New 24,033 $36K
Texas Capital Bank Wealth Management Services Inc 0.00% No change 23,750 $35K
Northern Trust Corp. 0.00% Add +17.5% 20,440 $30K
XTX Topco Ltd 0.00% Reduce -27.1% 12,433 $18K
Northwestern Mutual Wealth Management Co. 0.00% No change 2,785 $4K
Tower Research Capital LLC (TRC) 0.00% Reduce -48.4% 1,265 $2K
Jones Financial Companies LLLP 0.00% Reduce -37.5% 768 $1K
UBS Group AG 0.00% Reduce -38.2% 480 $710
BlackRock, Inc. 0.00% No change 84 $124
Rockefeller Capital Management L.P. 0.00% No change 83 $123

"% of holder's portfolio" is INAB's weight in each manager's 13F, not the share of IN8BIO Inc. the manager owns.